BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10680741)

  • 1. No apparent effect of cidofovir in epidermodysplasia verruciformis.
    Preiser W; Kapur N; Snoeck R; Groves RW; Brink NS
    J Clin Virol; 2000 Feb; 16(1):55-7. PubMed ID: 10680741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
    Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
    J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of intravenous cidofovir for generalized verrucosis in a patient with severe combined immunodeficiency.
    Potthoff A; Wieland U; Kreuter A
    Arch Dermatol; 2012 May; 148(5):659-60. PubMed ID: 22782169
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Calista D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
    Snoeck R; Van Laethem Y; De Clercq E; De Maubeuge J; Clumeck N
    Arch Intern Med; 2001 Oct; 161(19):2382-4. PubMed ID: 11606156
    [No Abstract]   [Full Text] [Related]  

  • 6. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
    Zabawski EJ; Cockerell CJ
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local treatment of HPV-induced skin lesions by Cidofovir.
    Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
    J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis.
    Tubridy N; Wells C; Lewis D; Schon F
    J R Soc Med; 2000 Jul; 93(7):374-5. PubMed ID: 10928027
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical cidofovir is effective in treating extensive penile condylomata acuminata.
    Schürmann D; Bergmann F; Temmesfeld-Wollbrück B; Grobusch MP; Suttorp N
    AIDS; 2000 May; 14(8):1075-6. PubMed ID: 10853999
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of adenoviral conjunctivitis with topical cidofovir.
    Gordon YJ; Naesens L; DeClercq E; Maudgal PC; Veckeneer M
    Cornea; 1996 Sep; 15(5):546. PubMed ID: 8862935
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
    Toro JR; Sanchez S; Turiansky G; Blauvelt A
    Dermatol Clin; 2003 Apr; 21(2):301-9. PubMed ID: 12757253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cidofovir.
    Jabs DA
    Arch Ophthalmol; 1997 Jun; 115(6):785-6. PubMed ID: 9194731
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-cancer agents. Will cidofovir be useful against cervical lesions?
    TreatmentUpdate; 2000 Sep; 12(6):6-7. PubMed ID: 12132464
    [No Abstract]   [Full Text] [Related]  

  • 15. Cidofovir for the treatment of Kaposi's sarcoma in an HIV-negative homosexual man.
    Fife K; Gill J; Bourboulia D; Gazzard B; Nelson M; Bower M
    Br J Dermatol; 1999 Dec; 141(6):1148-9. PubMed ID: 10722277
    [No Abstract]   [Full Text] [Related]  

  • 16. Cidofovir for cytomegalovirus retinitis.
    Kravcik S
    Ann Intern Med; 1997 Sep; 127(6):490-1. PubMed ID: 9313009
    [No Abstract]   [Full Text] [Related]  

  • 17. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
    Simonart T; Noel JC; De Clercq E; Snoeck R
    Clin Infect Dis; 1998 Dec; 27(6):1562. PubMed ID: 9868698
    [No Abstract]   [Full Text] [Related]  

  • 18. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
    Hammoud Z; Parenti DM; Simon GL
    Clin Infect Dis; 1998 May; 26(5):1233. PubMed ID: 9597261
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
    Descamps V; Duval X; Grossin M; Crickx B; Leport C
    Br J Dermatol; 2001 Mar; 144(3):642-3. PubMed ID: 11260042
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient.
    Ibarra V; Blanco JR; Oteo JA; Rosel L
    Acta Derm Venereol; 2000; 80(4):315-6. PubMed ID: 11028878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.